Does Medicare cover Yupelri?
Yes, but usually under Part B rather than Part D. Yupelri is a solution you breathe in through a nebulizer, and Medicare covers nebulizers as durable medical equipment along with the drugs used in them. Viatris states that "Medicare Part B also covers most nebulizers as durable medical equipment (DME) for patient use at home", that Part B covers 80% of nebulized COPD treatments like Yupelri, and that you pay the remaining 20%. Medicare Advantage plans cover it at the same 80% level. Confirm how your own supply is billed with your prescriber's office or DME supplier.
Will Medicare Extra Help lower my Yupelri cost?
Not if your Yupelri is billed under Part B, and that is the usual case. Extra Help is the Part D Low-Income Subsidy: it lowers Part D premiums, deductibles and copays. A Part B coinsurance is none of those, so Extra Help does not touch it. This is the most common and most expensive misunderstanding about nebulized drugs on Medicare. Extra Help is still worth having for your other medications, and qualifying for a
Medicare Savings Program brings it automatically — but for the Yupelri bill, Medigap and a Medicare Savings Program are the tools.
How do I get my 20% Yupelri coinsurance down to zero?
Supplemental coverage is the usual answer. Most standardised Medigap policies cover the Part B coinsurance, which is why Viatris can say that with a Medigap policy a patient "may pay as little as $0 out of pocket for YUPELRI". If a Medigap premium is out of reach, a Medicare Savings Program can cover the Part B deductible and coinsurance at some levels. And unlike Extra Help, the TotalAssist and HealthWell COPD grants do pay toward coinsurance, so they work for a Part B bill when they reopen.
Is there a Yupelri patient assistance program for people on Medicare?
Viatris runs a patient assistance program and publishes a contact route for it on the Yupelri site — ViatrisPAP@viatris.com, fax 877-427-7290 — but it does not publish the income limits, the insurance rules or any Medicare rule for it on those pages, and the Viatris patient-support page we tried returned a 404 error on August 26, 2026. So the honest answer is that a program exists and its criteria could not be established. Email or fax and ask whether Medicare beneficiaries qualify and whether Part B and Part D patients are treated differently — that last question matters more for Yupelri than for most medicines.
Can I use the Yupelri savings card with Medicare?
No. Viatris's terms say "This offer is not valid for patients covered by Medicare, Medicaid, or any other federal or state-funded healthcare program or where prohibited by law." Being covered by Medicare is the disqualifier, so it makes no difference whether your Yupelri runs through Part B or Part D. One further restriction worth noting even for commercially insured readers: absent a change in Massachusetts law, the savings program is no longer valid for Massachusetts residents as of January 1, 2026.
Is there a generic for Yupelri?
No. DailyMed lists a single labelled revefenacin product, Viatris's Yupelri. There is no generic version. If cost is the obstacle, the conversation worth having with your prescriber is not about a generic but about whether a handheld inhaler would suit you — those are Part D drugs, where Extra Help and the $2,100 out-of-pocket cap apply. That is a clinical decision, though: for some people a nebulizer is genuinely easier to use correctly. See
all prescription assistance options.